Forteo

Entera moves oral rival to Lilly's Forteo toward pivotal trial

Entera Bio has posted midphase data on its oral challenger to Eli Lilly’s injectable osteoporosis drug Forteo, setting it up to begin a phase 3 trial.

Nick Paul Taylor Oct 11, 2021 7:30am

Amgen prices bone drug Evenity on par with rival Tymlos

Apr 16, 2019 12:18pm

Amgen bone drug Evenity wins FDA nod, but with strings attached

Apr 10, 2019 10:38am

Court tosses kickbacks case against Eli Lilly

Aug 15, 2018 11:19am

Lilly CEO to pharma: Stop talking and get going on pricing

Jan 10, 2018 7:33am

Lawsuit claims Lilly used free nursing to boost insulin sales

Nov 16, 2017 11:20am